Tradestie Institutional Equity Comparison Engine

ANIK vs IG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ANIK Overall Edge

ANIK Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Anika Therapeutics Inc (ANIK) driven by superior Valuation, Growth & Margin, Momentum & Technical while IG counters with relative strength in Options & Structure. Fundamentally, ANIK trades at 12.9x Forward P/E with -0.1% operating margin (+10.0% YoY revenue) versus IG at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ANIK sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro) against IG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ANIK
ANIK 12.9x vs IG N/M Fwd P/E
Growth & Margin Winner ANIK
Op Margin -0.1% vs N/A ยท YoY +10.0% vs N/A
Momentum & Technical Winner ANIK
1Y +27.9% vs -6.1% ยท 52W Pos 28% vs 14%
Options & Structure Winner IG
BREAKDOWN (6th %ile IV) vs UNCLASSIFIED (N/A IV)
ANIK NASDAQ
Anika Therapeutics Inc
Surgical & Medical Instruments & Apparatus
$12.92
-3.58% 1D
Market Cap $179.5M
1M Return -35.34%
1Y Return +27.92%
Forward P/E 12.9x
Unified AI Score
48.5 / 100 HOLD
Tech 45.0 Fund 52.0 Flow 57.0 Mom 55.0
IG NYSE Arca
Principal Investment Grade Corporate Active ETF
Institutional Equity
$19.61
-0.02% 1D
Market Cap N/A
1M Return -0.61%
1Y Return -6.14%
Forward P/E N/M
Unified AI Score
45.4 / 100 HOLD
Tech 49.0 Fund 53.0 Flow 50.0 Mom 46.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ANIK +27.92% IG -6.14% Spread: +34.06 pp (ANIK Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ANIK TTM Op. Margin: -0.1% IG TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ANIK vs IG. Trailing 12-month operating profitability (ANIK -0.1% vs IG N/A) and valuation multiples (ANIK 12.9x vs IG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ANIK (9) vs IG (1)
Institutional Metric ANIK IG Criterion Row Winner
Market Capitalization Scale $179.5M N/A Larger Scale ANIK
Trailing P/E Ratio Valuation 13.4x N/M Lower Multiple ANIK
Forward P/E Ratio Valuation 12.9x N/M Lower Multiple ANIK
Revenue Growth (YoY) Growth +10.0% N/A Higher Growth ANIK
Operating Margin (TTM) Profitability -0.1% N/A Higher Margin ANIK
Net Profit Margin Profitability -1.4% N/A Higher Margin ANIK
Return on Equity (ROE) Capital Efficiency -0.2% N/A Higher ROE ANIK
52-Week Range Position Momentum 28% ($9โ€“$23) 14% ($19โ€“$21) Stronger Trend ANIK
Beta / 30D Volatility Risk Regime 0.91ฮฒ ยท 98% Vol 0.18ฮฒ ยท 7% Vol Lower Realized Risk IG
Unified Institutional Score Composite Signal 48.5 / 100 (HOLD) 45.4 / 100 (HOLD) Higher Composite ANIK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ANIK vs IG Buy Guide
ANIK BREAKDOWN
67d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live ANIK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ANIK nor IG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.